Down-regulated expression levels of MCM2 (mini-chromosome maintenance complex component 2), PARP1, and BRCA1 (breast cancer type 1) genes in CBD-treated HNSCC were confirmed by quantitative real-time RT-PCR and then compared with the RNA-seq results (Fig. 6C). The gene discussed is PARP1; the disease is breast cancer.